ENTERA BIO LTD. (ENTX) Reports the reporting period Financial Results
ENTERA BIO LTD. (ENTX) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: 42
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 4137
anticipated by Entera will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Entera. Therefore, no assurance can be given that the outcomes stated or implied in such forward-looking statements and estimates will be achieved. Entera cautions investors not to rely on the forward-looking statements Entera makes in this press release. The information in this press release is provided only as of the date of this press release, and Entera undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by law. Company Contact: IR@enterabio.com ENTERA BIO LTD. CONDENSED CONSOLIDATED BALANCE SHEETS (U.S. dollars in thousands) March 31, December 31, 2026
📋 ENTERA BIO LTD. (ENTX) - Financial Results
Filing Date: 2026-05-08
Accepted: 2026-05-08 16:05:27
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: